DK3365436T3 - Fremgangsmåder til fremstilling af en primær celleprøve - Google Patents
Fremgangsmåder til fremstilling af en primær celleprøve Download PDFInfo
- Publication number
- DK3365436T3 DK3365436T3 DK16791191.6T DK16791191T DK3365436T3 DK 3365436 T3 DK3365436 T3 DK 3365436T3 DK 16791191 T DK16791191 T DK 16791191T DK 3365436 T3 DK3365436 T3 DK 3365436T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparing
- methods
- primary cell
- cell sample
- sample
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
- C12N2501/734—Proteases (EC 3.4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562243765P | 2015-10-20 | 2015-10-20 | |
| PCT/US2016/057923 WO2017070353A1 (en) | 2015-10-20 | 2016-10-20 | Methods of preparing a primary cell sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3365436T3 true DK3365436T3 (da) | 2021-10-11 |
Family
ID=57233884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16791191.6T DK3365436T3 (da) | 2015-10-20 | 2016-10-20 | Fremgangsmåder til fremstilling af en primær celleprøve |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11591573B2 (https=) |
| EP (1) | EP3365436B1 (https=) |
| JP (2) | JP7202613B2 (https=) |
| KR (1) | KR102757122B1 (https=) |
| CN (1) | CN108138146A (https=) |
| AU (1) | AU2016341938B2 (https=) |
| CA (1) | CA2999054A1 (https=) |
| DK (1) | DK3365436T3 (https=) |
| WO (1) | WO2017070353A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016341938B2 (en) * | 2015-10-20 | 2022-12-01 | Celcuity Inc. | Methods of preparing a primary cell sample |
| CN108300688B (zh) * | 2018-02-07 | 2021-02-02 | 上海赛立维生物科技有限公司 | 原代肝细胞分离和培养方法 |
| CN109402051A (zh) * | 2018-12-28 | 2019-03-01 | 青岛麦迪赛斯生物科技有限公司 | 一种人脐带间充质干细胞无血清培养基 |
| CN109777736B (zh) * | 2019-01-29 | 2022-03-25 | 美闺(长沙)医疗美容有限公司 | 一种活细胞分析设备及方法 |
| CN109943520B (zh) * | 2019-03-08 | 2023-06-23 | 中国人民解放军军事科学院军事医学研究院 | 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用 |
| EP4073516A1 (en) | 2019-12-09 | 2022-10-19 | Celcuity Inc. | Methods of treating cancer patients with ras node or rtk targeted therapeutic agents |
| CN111733136B (zh) * | 2020-06-29 | 2021-11-30 | 中山大学孙逸仙纪念医院 | 一种提高CD90posi细胞分离效率的方法 |
| EP4425769A4 (en) | 2021-10-27 | 2025-11-05 | Sumitomo Bakelite Co | STATOR AND STRUCTURE |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0691400B1 (en) | 1993-12-30 | 2002-03-06 | Nitta Gelatin Inc. | Process for embedding culture of animal cells |
| US5858678A (en) | 1994-08-02 | 1999-01-12 | St. Louis University | Apoptosis-regulating proteins |
| US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| EP1824965B1 (en) | 2004-10-27 | 2011-10-05 | Vrije Universiteit Brussel | Hepatic differentiation of stem cells |
| FR2894594B1 (fr) * | 2005-12-12 | 2008-02-08 | Univ Limoges | Test predictif de reponse therapeutique du cancer du sein |
| CA2706293A1 (en) * | 2007-11-20 | 2009-05-28 | Hopitaux Universitaires De Geneve | Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof |
| WO2010026574A2 (en) | 2008-09-02 | 2010-03-11 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
| JP5774496B2 (ja) * | 2010-01-19 | 2015-09-09 | 株式会社ルネッサンス・エナジー・インベストメント | 癌組織由来細胞塊または癌細胞凝集塊の培養方法、評価方法および保存方法 |
| CN103025887A (zh) | 2010-05-03 | 2013-04-03 | 麦克罗斯特姆公司 | 筛选方法、由其确定的组合物、可用于其确定的工具和由其生产的细胞群 |
| TWI477599B (zh) | 2011-01-28 | 2015-03-21 | 鴻海精密工業股份有限公司 | 培育基體 |
| PT2764099T (pt) * | 2011-10-04 | 2018-02-28 | Mitra Rxdx India Private Ltd | Composição de ecm, plataforma de microambiente tumoral e seus métodos |
| US20130330761A1 (en) | 2012-06-12 | 2013-12-12 | Celcuity, LLC | Whole cell assays and methods |
| US20140142000A1 (en) * | 2012-10-25 | 2014-05-22 | Academia Sinica | Microfluidic array platform for simultaneous cell culture under oxygen tensions |
| GB2516196B (en) * | 2013-01-25 | 2015-09-09 | Xcell Biosciences Inc | Methods, compositions, kits, and systems for selective enrichment of target cells |
| GB201303491D0 (en) * | 2013-02-27 | 2013-04-10 | Cancer Rec Tech Ltd | Culture of leukemia initiating cells |
| WO2015089380A2 (en) * | 2013-12-12 | 2015-06-18 | Celcuity Llc | Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent |
| WO2015156929A1 (en) * | 2014-04-07 | 2015-10-15 | The Trustees Of Columbia University In The City Of New York | Method for culture of human bladder cell lines and organoids and uses thereof |
| AU2016341938B2 (en) * | 2015-10-20 | 2022-12-01 | Celcuity Inc. | Methods of preparing a primary cell sample |
-
2016
- 2016-10-20 AU AU2016341938A patent/AU2016341938B2/en not_active Ceased
- 2016-10-20 JP JP2018520106A patent/JP7202613B2/ja active Active
- 2016-10-20 EP EP16791191.6A patent/EP3365436B1/en active Active
- 2016-10-20 CN CN201680061008.6A patent/CN108138146A/zh active Pending
- 2016-10-20 DK DK16791191.6T patent/DK3365436T3/da active
- 2016-10-20 KR KR1020187010765A patent/KR102757122B1/ko active Active
- 2016-10-20 WO PCT/US2016/057923 patent/WO2017070353A1/en not_active Ceased
- 2016-10-20 CA CA2999054A patent/CA2999054A1/en active Pending
-
2018
- 2018-04-11 US US15/950,739 patent/US11591573B2/en active Active
-
2021
- 2021-08-12 JP JP2021131632A patent/JP2021175415A/ja active Pending
-
2023
- 2023-01-23 US US18/100,437 patent/US12215356B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1252635A1 (zh) | 2019-05-31 |
| US11591573B2 (en) | 2023-02-28 |
| US20180230434A1 (en) | 2018-08-16 |
| KR102757122B1 (ko) | 2025-01-21 |
| KR20180057653A (ko) | 2018-05-30 |
| JP2021175415A (ja) | 2021-11-04 |
| EP3365436B1 (en) | 2021-09-08 |
| WO2017070353A1 (en) | 2017-04-27 |
| EP3365436A1 (en) | 2018-08-29 |
| AU2016341938B2 (en) | 2022-12-01 |
| AU2016341938A1 (en) | 2018-04-26 |
| JP2018531021A (ja) | 2018-10-25 |
| CA2999054A1 (en) | 2017-04-27 |
| US12215356B2 (en) | 2025-02-04 |
| US20230235293A1 (en) | 2023-07-27 |
| CN108138146A (zh) | 2018-06-08 |
| JP7202613B2 (ja) | 2023-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3374748T3 (da) | Fremgangsmåde til udarbejdelse af et prøveforsøg | |
| DK3519094T3 (da) | System til forberedelse af en prøve | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| DK3186376T3 (da) | Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet | |
| DK3444334T3 (da) | Fremgangsmåde til inducering af CD8+ T-celler | |
| DK3285784T3 (da) | Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3940352T3 (da) | Fremgangsmåde til diagnosticering af vægte | |
| DK3110988T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK3789042T3 (da) | Fremgangsmåde til fremstilling af anti-her3-antistof-lægemiddelkonjugat | |
| DK3247201T3 (da) | Fremgangsmåder til opgradering af brugt biomassemateriale | |
| DK3529611T3 (da) | Fremgangsmåder til screening af b-cellelymfocytter | |
| DK3152176T5 (da) | Fremgangsmåde til fremstillingen af en cementforbindelse | |
| DK3344805T3 (da) | Fremgangsmåde til udvælgelse af aptamerer til ubundne mål | |
| DK3376923T3 (da) | Fremgangsmåde til tilberedning af en drik | |
| DK3365436T3 (da) | Fremgangsmåder til fremstilling af en primær celleprøve | |
| DK3529233T3 (da) | Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3393660T3 (da) | Fremgangsmåde til fremstilling af en tæt beholder | |
| DK3195345T3 (da) | Fremgangsmåde til karakterisering af en prøve ved billeddannelse ved massespektrometri | |
| DK3367910T3 (da) | Fremgangsmåde til anvendelse af en sondeafdækning | |
| DK3274143T3 (da) | Fremgangsmåde til fremstilling af lignocellulosematerialer | |
| DK3304037T3 (da) | Fremgangsmåde til opsamling af cellekolonier | |
| DK3384045T3 (da) | Fremgangsmåde til bestemmelse af celleklonalitet | |
| IL275288B1 (en) | Methods for obtaining muscle derived cells |